SAR-444245
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SAR-444245, covering 2025-10-02 to 2025-10-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study of SAR444245 With or Without Other Anticancer Therapies for the Treatment of Adults and Adolescents With Relapsed or Refractory B Cell Lymphoma (Master Protocol) [Pegathor Lymphoma 205] [Phase 2]